These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study. Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047 [TBL] [Abstract][Full Text] [Related]
4. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study. Szemraj J; Stankiewicz A; Rozmyslowicz-Szermińska W; Mogielnicki A; Gromotowicz A; Buczko W; Oszajca K; Bartkowiak J; Chabielska E Thromb Haemost; 2007 Jun; 97(6):1037-45. PubMed ID: 17549308 [TBL] [Abstract][Full Text] [Related]
5. Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation. Kwiecinski J; Peetermans M; Liesenborghs L; Na M; Björnsdottir H; Zhu X; Jacobsson G; Johansson BR; Geoghegan JA; Foster TJ; Josefsson E; Bylund J; Verhamme P; Jin T J Infect Dis; 2016 Jan; 213(1):139-48. PubMed ID: 26136471 [TBL] [Abstract][Full Text] [Related]
6. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini. He J; Di J; Xu R; Zhao B Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183 [TBL] [Abstract][Full Text] [Related]
7. Staphylokinase as a plasminogen activator component in recombinant fusion proteins. Szarka SJ; Sihota EG; Habibi HR; Wong S Appl Environ Microbiol; 1999 Feb; 65(2):506-13. PubMed ID: 9925575 [TBL] [Abstract][Full Text] [Related]
8. Lipid modification of staphylokinase and its implications on stability and activity. Mannully ST; Shanthi C; Pulicherla KK Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946 [TBL] [Abstract][Full Text] [Related]
9. Cloning & expression of SAK enzyme from Muttar A; Numan IT J Med Life; 2022 Jun; 15(6):768-771. PubMed ID: 35928367 [TBL] [Abstract][Full Text] [Related]
10. C-terminal lysine residues enhance plasminogen activation by inducing conformational flexibility and stabilization of activator complex of staphylokinase with plasmin. Kaur P; Sethi D; Hade MD; Kaur J; Dikshit KL Arch Biochem Biophys; 2023 Jul; 743():109671. PubMed ID: 37336343 [TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant. Kowalski M; Brown G; Bieniasz M; Oszajca K; Chabielska E; Pietras T; Szemraj Z; Makandjou-Ola E; Bartkowiak J; Szemraj J Acta Biochim Pol; 2009; 56(1):41-53. PubMed ID: 19018330 [TBL] [Abstract][Full Text] [Related]
12. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections. Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118 [TBL] [Abstract][Full Text] [Related]
14. Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase. Xu Y; Shi Y; Zhou J; Yang W; Bai L; Wang S; Jin X; Niu Q; Huang A; Wang D Microb Cell Fact; 2017 Nov; 16(1):197. PubMed ID: 29137636 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor. Sakai M; Watanuki M; Matsuo O Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034 [TBL] [Abstract][Full Text] [Related]
16. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase. Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624 [TBL] [Abstract][Full Text] [Related]
17. Novel self-cleavage activity of Staphylokinase fusion proteins: An interesting finding and its possible applications. Prasad B; Salunkhe SS; Padmanabhan S Protein Expr Purif; 2010 Feb; 69(2):191-7. PubMed ID: 19638310 [TBL] [Abstract][Full Text] [Related]
18. Staphylokinase reduces plasmin formation by endogenous plasminogen activators. Jin T; Bokarewa M; Zhu Y; Tarkowski A Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597 [TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin. Okada K; Yuasa H; Hagiya Y; Fukao H; Ueshima S; Matsuo O Thromb Res; 1994 Oct; 76(2):181-91. PubMed ID: 7863467 [TBL] [Abstract][Full Text] [Related]